Autres langues FreeT, Inc.

Actions

A006490

KR7006490007

Services de télécommunications sans fil

Cours en clôture Korea S.E. Autres places de cotation 22/07/2026			Varia. 5j.	Varia. 1 janv.
1 002,00 ^KRW	-8,58%		-35,35%	-68,34%

15/05/23

Inscobee, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2023

Autres langues

02/06	Inscobee Appoints Song Byung-Kwon as CEO
26/05	Inscobee., Inc. has Changed its Name to freeT
15/05	FreeT, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
30/04	Inscobee., Inc. announced that it expects to receive KRW 5 billion in funding from Smsolrution Inc.
07/04	Inscobee., Inc. announced that it has received KRW 10 billion in funding from KS Industry Co., Ltd.
03/04	Inscobee., Inc. announced that it expects to receive KRW 10 billion in funding
31/03	Inscobee., Inc. announced that it expects to receive KRW 10 billion in funding from KS Industry Co., Ltd.
26/08/25	Inscobee., Inc.(KOSE:A006490) dropped from S&P Global BMI Index
25/06/25	Inscobee., Inc. announced that it has received KRW 5 billion in funding
24/04/25	Inscobee., Inc. announced that it expects to receive KRW 5 billion in funding
21/03/25	Cellumed Co.,Ltd. announced that it has received KRW 5.000001121 billion in funding from Inscobee., Inc.
18/03/25	Inscobee., Inc. announced that it has received KRW 5 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank
13/03/25	Cellumed Co.,Ltd. announced that it expects to receive KRW 5.000001121 billion in funding from Inscobee., Inc.
05/03/25	Inscobee., Inc. announced that it has received KRW 2.35 billion in funding
05/03/25	Apimeds Pharmaceuticals US, Inc. announced that it has received KRW 8.7522 billion in funding from Inscobee., Inc.
04/03/25	Apimeds Pharmaceuticals US, Inc. announced that it expects to receive KRW 8.7522 billion in funding from Inscobee., Inc.
21/02/25	Inscobee., Inc. announced that it expects to receive KRW 2.35 billion in funding
17/12/24	Dominus IB, Inc. agreed to acquire additional 17.71% stake in Apimeds Pharmaceuticals US, Inc. from Inscobee., Inc. for KRW 7,840 million.
22/11/24	Inscobee., Inc. announced that it has received KRW 1 billion in funding
18/11/24	Inscobee., Inc. announced that it expects to receive KRW 1 billion in funding
04/10/24	Inscobee., Inc. announced that it has received KRW 1.8 billion in funding
06/08/24	Inscobee., Inc. announced that it has received KRW 2.8 billion in funding
01/08/24	Inscobee., Inc. announced that it expects to receive KRW 2.8 billion in funding
04/03/24	Inscobee., Inc. announced that it expects to receive KRW 12 billion in funding from Sangsangin Investment & Securities Co.,Ltd.
15/05/23	Inscobee., Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023